Literature DB >> 25086140

Longterm followup of quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab, an anti-interleukin 1β monoclonal antibody.

Céline Marsaud1, Isabelle Marie2, Isabelle Koné-Paut2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25086140     DOI： 10.3899/jrheum.131291

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  2 in total

1.  [Papillary edema in Muckle-Wells syndrome].

Authors:  G Wirths; U Grenzebach; N Eter
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

2.  Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  Nafissa Mamoudjy; Hélène Maurey; Isabelle Marie; Isabelle Koné-Paut; Kumaran Deiva
Journal:  Orphanet J Rare Dis       Date:  2017-02-14       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.